Literature DB >> 22984423

Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma.

Yun Shi1, Guo-jun Luo, Li Zhang, Ji Shi, Dao-quan Zhang, Jian-min Chen, Xiao-bo Chen, Zhuo-dong Li, Qing Zhao.   

Abstract

OBJECTIVES: The purpose of this study is to explore the relationship between the interactions of CYP2C19 gene polymorphisms and several environmental factors and oesophageal squamous cell carcinoma (OSCC).
METHODS: In a case-control study of OSCC patients (n = 350) and healthy controls (n = 350), we investigated the roles of polymorphism in the CYP2C19 gene by the use of polymerase chain reaction--restriction fragment length polymorphism (PCR - RFLP) analysis.
RESULTS: The CYP2C19(*)3 AG+AA genotype was significantly more prevalent in OSCC patients (10.0% versus 3.43%; P<0.01). Multiple logistic regression analysis showed drinking (OR: 5.603, 95% CI: 3.431-11.112; P = 0.005) and smoking (OR: 4.341, 95% CI: 3.425-10.241; P = 0.001) was the independent risk factor of OSCC respectively, and there were significant interaction between CYP2C19(*)3 and drinking (OR: 8.747, 95% CI: 6.321-18.122; P = 0.009).
CONCLUSIONS: The CYP2C19(*)3 polymorphism and OSCC were synergistically and significantly associated in Chinese Han patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22984423      PMCID: PMC3439450          DOI: 10.1371/journal.pone.0043412

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Oesophageal squamous cell carcinoma (OSCC) is a common cancer among people in China [1]. Cancer registries established in the 1960s showed extremely high incidence rates of OSCC in China [2]. Known causes of OSCC, most notably tobacco and alcohol consumption could not explain this high incidence [2], [3]. It is generally accepted that OSCC is a complex disease resulting from the interaction between genetic and environmental factors [4], [5]. Several environmental risk factors such as smoking, alcohol drinking, prolonged use of wood or charcoal as sources of fuel for cooking and heating (resulting in excessive smoke inhalation), have been reported to be associated with OSCC [6]. Recent data imply that the environmental risk factors may be modified by polymorphisms in the carcinogen metabolizing genes i.e. gene-environment interactions [7]. Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs). Current researches suggested that some CYP isoforms, such as CYP1A [8], CYP2B [9], CYP2C [10], CYP2D [11], participate arachidonic acid metabolism. CYP2C19, one human cytochrome P450 enzyme, is not only a clinically important metabolic enzyme responsible for the metabolism of a number of therapeutic drugs but also the key enzyme of EETs synthesis and abundantly expressed in endothelial and smooth muscle cells [12], [13] Recently, there were several studies concerning the CYP2C19 polymorphism and cancer susceptibility [14]–[17]. Isomura et al. [14] investigated the role of genetic polymorphism of CYP2C19 in a total of 114 cell lines of five gastroenterological cancers and found among the 114 cell lines, biliary tract cancer was suggested to be most strongly associated with poor metabolizers of CYP2C19. Afsar and colleagues [15] also found the frequency of CYP2C19 variant is very high in breast cancer patients. Yadav et al. [16] suggested that synergism amongst the poor metabolizers of CYP2C19 interact significantly with environmental risk factors in modifying the susceptibility to squamous cell carcinoma of head and neck (HNSCC). Bozina et al. [17] have summarized the relationships between some CYPs genetic polymorphisms and cancer risks. Recently, a common genetic variant, CYP2C19*3 (G636A) gene was reported in some studies [18]. This polymorphism, 636 G→A substitution in the exon 4 region, changes the tryptophan codon to the termination codon that leads to the protein synthesis stopping earlier and the protein incompetency for the deficiency connective zone of the hemochrome and the substrate [18]. Several studies revealed that the CYP2C19*3 allele carriers have decreased metabolic capacity for some drugs such as omeprazole, chloroguanide, and certain tricyclic antidepressants. Individuals can be divided into two groups, poor metabolizers (PMs) and extensive metabolizers (EMs), depending on the ability of 4′-hydroxylate-S-mephenytoin. However, the role of this gene variant in OSCC has not been sufficiently investigated. Normally, Asian people had a higher incidence of CYP2C19*3, which was usually about 13–16%, but in Caucasian people it was only 1–3% as well [19]. Therefore, it is very interesting to see if the high incidence of OSCC correlates with increased frequency of the CYP2C19*3 in Chinese population variant. In the present study, we hypothesized that those with the CYP2C19*3 may have a higher risk for OSCC. We also speculated that there should be a synergistic interaction between the effect of several environmental factors and the genetic variation for the OSCC.

Materials and Methods

Ethics Statement

The present study was approved by the Ethics Committee of the Kunming General Hospital of Chengdu Military Region.

Subjects

All the patients (n = 350) were diagnosed with histologically confirmed OSCC at Kunming General Hospital of Chengdu Military Region. Controls (n = 350) were age, sex, and geographically-matched individuals to the patients but with no obvious sign of disease. Controls with prior history of cancer were excluded. The patients and controls were recruited between 2009 and 2011. And both the patients and the controls are the Chinese Han ethnic origin.

Sample DNA extraction

Blood samples were collected with a standard venipuncture technique and EDTA-containing tubes. DNA was extracted from peripheral vein blood leukocytes using a whole blood genome extraction kit (Beijing Boiteke Corporation) according to the manufacturer's instructions. Samples were coded to protect donor identity and to allow blinding of the investigators who carried out the genotyping.

Data Collection

A standard questionnaire was administered to cases and controls by trained medical doctors to elicit information on demographic variables, including cigarette smoking, drinking history, fruit and vegetable intake, family history of cancer, and prolonged use of wood or charcoal as sources of fuel for cooking and heating (Excessive smoke inhalation). Persons reporting regular tobacco use in the previous 6 months were considered as smoker. Persons who were ingesting alcohol in the last 6 months were considered to be alcohol dinking [20]. A family history of OSCC is defined as having an unusually high number of close relatives with OSCC. For quantification of fruit and vegetable intake, 70 grams was considered an average portion of vegetables (both fresh and cooked vegetables included) and 100 grams was considered an average portion of fruit [21]. Participants were classified as consuming ≥2 portions/day if they regularly consumed at least one portion of fruit and one portion of vegetables per day or if they consumed at least 2 portions of fruit or 2 portions of vegetables per day.

Genotyping of CYP2C19*3 polymorphism

Genotyping was confirmed by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis according to the protocol described previously [22]. Briefly, the forward primer is 5′- CATCCTGGGCTGTGCT-3′; and the reverse primer is 5′- AGGGCTTTGGAGTTTAGTG-3′; annealing temperature is 52°C. The PCR product (15 µL) was incubated with BamH I (Fermentas corporation) 5U in a total volume of 25 µL overnight at 37°C, and the resulting fragments were separated on a 1.5% agarose gel. The presence of the G636A variant creates a BamH I site producing two fragments of 263, and 133 bp. To ensure the results to be verified, we used sequenced genomic DNAs as positive controls in our assays.

Statistical analysis

To test the hypothesis that the frequency of the CYP2C19*3 in the OSCC patients (7%) is more than that in the control subjects (2%). It was estimated that a total of 700 subjects would be needed to ensure a power of 80% to detect a 5% difference between the 2 groups using a 2-tailed test, with a sampling ratio of case: control group at 1∶1, bilateral risk set at 5%. Data analysis was performed using the computer software Statistical Package for Social Sciences-SPSS for Windows (version 13.0, SPSS Institute, Chicago, IL). Hardy-Weinberg equilibrium was assessed by chi-square analysis. Differences in enumeration data between the cases and the controls were analyzed using the Chi-square test. Differences in distributions of genotypes and alleles between the cases and the controls were analyzed using Chi-square test. Allele frequencies distribution was analyzed by 2×2 contingency tables using a 5% level of significance. Logistic regression analysis was used to estimate the odds ratio (OR) and its 95% confidence interval (CI) as a measure of the association between polymorphism of CYP2C19 and risk of OSCC. We performed the gene-environmental interaction analysis according to the protocol described on the website http://jxzy.smu.edu.cn/151/PrjFile/lxb/showdown.asp?soft_id=244.

Results

General characteristics of the participants

General characteristics of the study population are presented in Table 1. There were not significantly different between the OSCC patients and the control subjects in age and gender (both P>0.05). However, there were significant differences in smoking, drinking, fruit and vegetables intake, prolonged use of wood or charcoal as sources of fuel for cooking and heating, and family history of cancer between the cases and the controls (all P<0.05).
Table 1

Clinical characteristics of study participants.

OSCC (n = 350)Control (n = 350) P
Age (years ±SD)59.4±12.560.7±12.40.098
Male gender (n, %)212 (60.57)204 (57.47)0.365
Smoking (n, %)237 (67.71)165 (47.14)<0.001
Alcohol drinker (n, %)219 (62.57)125(35.71)<0.001
Fruit and vegetables intake (n, %)
≥2 portions/day146 (41.71)247 (70.57)<0.001
<2 portions/day204 (58.39)103 (29.43)
Family history of cancer (n, %)135 (38.57)75 (21.43)<0.001
Excessive smoke inhalation (n, %)188 (53.71)109 (31.14)<0.001

Distribution of the CYP2C19*3 genotype

The genotype distribution of CYP2C19*3 did not show any significant difference from Hardy-Weinberg equilibrium (P = 0.47).The frequency of the CYP2C19*3 A allele was significantly higher in OSCC patients than in controls (5.57% versus 1.86%; P = 0.004). The CYP2C19*3 AG+AA genotype was significantly more prevalent in OSCC patients (10.00% versus 3.43%; P<0.001, table 2). The power calculated for the study was 0.87.
Table 2

Genotype distribution of CYP2C19*3 polymorphism.

groupsnAlelle (n, %)Genotype (n, %)
AGAAAGGG
Cases35039 (5.57)661 (94.43)4 (1.14)31 (8.86)315 (90.00)
Controls35013 (1.86)687 (98.14)1 (0.29)11 (3.14)338 (96.57)

Associations of traditional risk factors with OSCC

By univariate analysis, all these environmental factors including smoking, drinking, <2 portions/day of fruit and vegetables intake, and excessive smoke inhalation were associated with OSCC, and there were significant interactions between CYP2C19*3 polymorphism and these environmental factors(all P<0.05, table 3). However, in a multivariate analysis, we only found the interaction between CYP2C19*3 and drinking remains significant (OR: 8.747; 95%CI: 6.321–18.122; interaction P = 0.009; Table 4).
Table 3

Association of traditional risk factors with the CYP2C19*3 genotype on OSCC.

Traditional risk factorsCYP2C19*3 genotypeCases (n)Controls (n)OR95%CI
Smoking
NoGG1051771*
NoAA+AG881.691.033–5.462
YesGG2101612.201.543–8.134
YesAA+AG27411.386.116–23.445
Drinking
NoGG1152191*
NoAA+AG1663.422.421–8.332
YesGG2001195.053.371–10.712
YesAA+AG19610.258.121–24.243
Fruit and vegetables intake
≥2 portions/dayGG1282421*
≥2 portions/dayAA+AG853.031.454–6.136
<2 portions/dayGG177963.492.100–8.342
<2 portions/dayAA+AG2777.293.697–13.154
Excessive smoke inhalation
NoGG1532331*
NoAA+AG981.711.011–3.189
YesGG1621052.351.021–6.108
YesAA+AG2649.904.112–18.243

Data are presented as number of patients. CI: confidence interval; OR: odds ratio.

as reference.

Table 4

Logistic regression analysis results.

Risk factorsβSEWald χ2 P OR 95%CI
drinking0.6510.4138.0120.0055.6033.431–11.112
smoking1.3210.32211.0230.0014.3413.425–10.241
CYP2C19* Drinking$ 0.6130.4116.0120.0098.7476.321–18.122
Fruit and vegetables intake1.2250.4653.0110.0655.212.291–8.134
Excessive smoke inhalation0.7660.4333.3350.0586.224.121–10.153

:the interaction between drinking and CYP2C19*3 A allele.

Data are presented as number of patients. CI: confidence interval; OR: odds ratio. as reference. :the interaction between drinking and CYP2C19*3 A allele.

Limitation of this study

The present study was limited by the relatively small sample size. This may have led to weak statistical significance and wide CIs when estimating odds ratios. And in the present study, we did not perform the functional experiment which is worthy doing in the future.

Discussion

In the present study, we found the CYP2C19*3 polymorphism was associated with OSCC in Chinese population. There was also significant synergism between this polymorphism and drinking for the OSCC. To our knowledge, this is the first study to report this gene-environment interaction between drinking and the CYP2C19*3 polymorphism on the risk of OSCC in Chinese population. Cytochrome P450s are the main drug metabolizing enzymes in human body, and are always found to participate in the metabolism of carcinogens or procarcinogens. CYP2C19 is one of the most important cytochrome P450s and is known as a key enzyme in the in vivo metabolism of a number of related hydantoins and barbiturates, as well as in the metabolism of structurally unrelated drugs such as omeprazole, lansoprazole, progunil, mephenytoin and citalopram [23]. CYP2C19*3 is a single base pair G636 A mutation in exon 4 of CYP2C19 which results in a premature stop codon [18]. In the present study, we found participants who carried the CYP2C19*3 A allele (AA or AG genotype) have a higher risk of OSCC compared with GG genotype carriers. Among participants carrying CYP2C19*3 GG genotypes, drinking was associated with about 5.603-fold higher risk (OR = 5.603, 95% CI: 3.431–11.112). However, drinking and carrying CYP2C19*3 A allele (AA or AG genotype) would be associated with an 8.747-fold risk for OSCC (OR = 8.747, 95% CI: 6.321–18.122) when compared with non-dinking CYP2C19*3 GG genotypes. These results indicates there was a significant interaction between CYP2C19*3 and dinking on the OSCC. In addition, we also found that for the CYP2C19*3 A allele carriers, smoking, less than 2 portions per day of fruit and vegetables intake, and prolonged use of wood or charcoal as sources of fuel for cooking and heating (resulting in excessive smoke inhalation) increase a 11.38-fold, 7.29-fold, and 9.90-fold risk for OSCC, respectively. However, by multiple logistic analysis, these interactions did not remains significant. In conclusion, we found a significant association between the CYP2C19*3 polymorphism and OSCC in Chinese people. There is significant synergetic effect between CYP2C19*3 polymorphism and drinking on the risk factor for OSCC.
  20 in total

1.  Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids.

Authors:  K Node; X L Ruan; J Dai; S X Yang; L Graham; D C Zeldin; J K Liao
Journal:  J Biol Chem       Date:  2001-02-22       Impact factor: 5.157

Review 2.  Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.

Authors:  Nada Bozina; Vlasta Bradamante; Mila Lovrić
Journal:  Arh Hig Rada Toksikol       Date:  2009-06       Impact factor: 1.948

3.  The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.

Authors:  Cristiano Fava; Martina Montagnana; Peter Almgren; Lena Rosberg; Giuseppe Lippi; Bo Hedblad; Gunnar Engström; Göran Berglund; Pietro Minuz; Olle Melander
Journal:  Hypertension       Date:  2008-06-23       Impact factor: 10.190

Review 4.  Epoxygenase metabolites. Epithelial and vascular actions.

Authors:  J D Imig
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

5.  Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.

Authors:  Stephan Fichtlscherer; Stefanie Dimmeler; Susanne Breuer; Rudi Busse; Andreas M Zeiher; Ingrid Fleming
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

6.  Is 'five-a-day' an effective way of increasing fruit and vegetable intakes?

Authors:  P A L Ashfield-Watt; A A Welch; N E Day; S A Bingham
Journal:  Public Health Nutr       Date:  2004-04       Impact factor: 4.022

Review 7.  Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis.

Authors:  Kerstin Lundell; Kjell Wikvall
Journal:  Curr Drug Metab       Date:  2008-05       Impact factor: 3.731

8.  Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.

Authors:  Wei-Xing Shi; Shu-Qing Chen
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

9.  Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis.

Authors:  B Ercan; L Ayaz; D Ciçek; L Tamer
Journal:  Cell Biochem Funct       Date:  2008-04       Impact factor: 3.685

10.  Association of a deletion of GSTT2B with an altered risk of oesophageal squamous cell carcinoma in a South African population: a case-control study.

Authors:  Marco Matejcic; DongPing Li; Natalie J Prescott; Cathryn M Lewis; Christopher G Mathew; M Iqbal Parker
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

View more
  10 in total

1.  Genetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han population.

Authors:  Weifeng Tang; Sheng Zhang; Hao Qiu; Lixin Wang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

2.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

3.  Individuals having variant genotypes of cytochrome P450 2C19 are at increased risk of developing primary liver cancer in Han populations, without infection with the hepatitis virus.

Authors:  Qiao-Yan Li; Ning-Min Zhao; Lian-Cai Wang; Hong-Fei Duan; Yong-Cheng Ma; Wei Zhang; Hong-Wei Zhao; Yu-Hua Qin
Journal:  Tumour Biol       Date:  2014-06-07

4.  Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis.

Authors:  Chao Liu; Yafeng Wang; Heping Jiang; Weifeng Tang; Shuchen Chen; Mingqiang Kang; Changqing Dong; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Quantitative assessment of the influence of cytochrome P450 2C19 gene polymorphisms and digestive tract cancer risk.

Authors:  Le Yao; Hong-Cheng Wang; Jia-Zhe Liu; Zhao-Ming Xiong
Journal:  Tumour Biol       Date:  2013-06-12

6.  Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.

Authors:  Rumaisa Rafiq; Gulzar Ahmad Bhat; Mohd Maqbool Lone; Akbar Masood; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2016-01-29

7.  Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India.

Authors:  G A Bhat; I A Shah; R Rafiq; S Nabi; B Iqbal; M M Lone; F Islami; P Boffetta; N A Dar
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

8.  Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects.

Authors:  Bo Zhou; Zhenshun Song; Mingping Qian; Liang Li; Jian Gong; Shaowu Zou
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

9.  Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.

Authors:  Weifeng Tang; Hao Qiu; Hao Ding; Bin Sun; Lixin Wang; Jun Yin; Haiyong Gu
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  Independent and combined effects of environmental factors and CYP2C19 polymorphisms on the risk of esophageal squamous cell carcinoma in Fujian Province of China.

Authors:  Xian-E Peng; Hua-Fang Chen; Zhi-Jian Hu; Xi-Shun Shi
Journal:  BMC Med Genet       Date:  2015-03-17       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.